Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

VIETNAM’S CANCER PREVENTION SHIFT: HOW HPV DNA SCREENING COULD REDEFINE THE FUTURE OF WOMEN’S HEALTHCARE

08/07/2026 Published by PhamTuThu

Key Development Vietnam is taking a new step toward preventive healthcare as Hai Phong develops a co-payment model for HPV... Read more

Tags: #Vietnam

VIETNAM’S SHIFT TOWARD PREVENTIVE HEALTHCARE: HOW DIGITAL HEALTH DATA IS CHANGING THE FUTURE OF CARE

08/07/2026 Published by PhamTuThu

Key Development Ho Chi Minh City is accelerating a large-scale public health initiative focused on expanding health checkups and strengthening... Read more

Category: Uncategorized

Tags: #Vietnam

KAILERA’S ORAL GLP-1 BREAKTHROUGH: THE NEXT CHAPTER OF THE GLOBAL OBESITY DRUG RACE

08/07/2026 Published by PhamTuThu

Key Development The global obesity drug market is entering a new phase as Kailera Therapeutics’ oral GLP-1 candidate HRS-7535 (KAI-7535)... Read more

Category: Uncategorized

Tags: #Global Trends

ASTRAZENECA’S $1.9B CHINA BET: WHY RESPIRATORY INNOVATION IS BECOMING BIG PHARMA’S NEXT BATTLEGROUND

08/07/2026 Published by PhamTuThu

Key Development AstraZeneca has expanded its strategic partnership with China’s pharmaceutical sector through a licensing agreement with Sino Biopharmaceutical worth... Read more

Category: Uncategorized

Tags: #GlobalTrends

VERTEX’S $10 BILLION BET ON CRINETICS SIGNALS THE NEXT PHASE OF RARE DISEASE CONSOLIDATION

08/07/2026 Published by PhamTuThu

Key Development Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a transaction valued at approximately US$10 billion, marking one... Read more

Category: Uncategorized

Tags: #GlobalTrends

Europe Moves Bispecific Antibodies Earlier in Follicular Lymphoma Care as AbbVie Secures New Regulatory Milestone

07/07/2026 Published by PhamTuThu

Key Development The European Commission has approved AbbVie and Genmab's bispecific antibody TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab... Read more

Category: Uncategorized

Tags: #GlobalTrends

Post-Pandemic Restructuring: BioNTech Executes Confidential Divestment Talks Over 4 German Manufacturing Sites to Fund Oncology Pivot

06/07/2026 Published by Pharma Biz

Key Development German biotechnology pioneer BioNTech SE—the co-developer of the blockbuster Comirnaty mRNA COVID-19 vaccine—has initiated highly confidential discussions with... Read more

Category: Uncategorized

Tags: #M&A

Blockbuster ADC Consolidation: Novartis Deploys $1.5 Billion to Acquire Myricx Bio, Securing Next-Gen Payload Platforms to Overcome Tumor Resistance

06/07/2026 Published by Pharma Biz

Key Development Swiss pharmaceutical major Novartis has formally entered into a definitive agreement to acquire U.S./U.K.-based biotechnology innovator Myricx Bio... Read more

Category: Uncategorized

Tags: #M&A

More Than a New Therapy: Vietnam’s Hyperkalemia Breakthrough Reshapes Cardiorenal Care

06/07/2026 Published by PhamTuThu

Executive Summary Vietnam has expanded access to sodium zirconium cyclosilicate (SZC), a next-generation oral potassium binder for hyperkalemia, through the... Read more

Category: Uncategorized

Tags: #Vietnam

Posts pagination

Previous page Page 1 … Page 36 Page 37 Page 38 … Page 200 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members